ArticleAntimicrobial agents and chemotherapy2014

Musculoskeletal safety outcomes of patients receiving daptomycin with HMG-CoA reductase inhibitors.

Christopher M Bland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.